Defective barrier function in neosquamous epithelium

American Journal of Gastroenterology

Volumn 108, Issue 3, 2013, Pages 386-391

  Jovov, Biljana ^a   Shaheen, Nicholas J ^a   Orlando, Geraldine S ^a   Djukic, Zorka ^a   Orlando, Roy C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN; CLAUDIN 4; FLUORESCEIN;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTRIC RESISTANCE; ELECTRON MICROSCOPY; ENDOSCOPIC BIOPSY; EOSINOPHILIA; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; FEMALE; FLUORESCENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INTERCELLULAR SPACE; MALE; MICROSCOPY; NEOSQUAMOUS EPITHELIUM; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIOFREQUENCY ABLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS EPITHELIUM; TIGHT JUNCTION;

AGED; BARRETT ESOPHAGUS; CATHETER ABLATION; CLAUDINS; EPITHELIAL CELLS; EPITHELIUM; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERMEABILITY; TIGHT JUNCTIONS;

EID: 84875224141     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.440     Document Type: Article

References (26)

1. Shaheen NJ, Richter JE. Barrett?soesophagus. Lancet 2009; 373: 850-61.
2. Spechler SJ. Barrett's esophagus. In: Orlando RC (ed) Gastroesophageal Reflux Disease. New York: Marcel Dekker, Inc; 2000, pp. 219-58.
3. Orlando RC. Mucosal Defense in Barrett's Esophagus. In: Sharma P, Sampliner R (eds) Barrett's Esophagus and Esophageal Adenocarcinoma, 2nd Edition, Blackwell Publishing: Oxford, UK, 2006, pp. 60-72.
4. Jovov B, Van Itallie CM, Shaheen NJ et al. Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance. Am J Physiol Gastrointest Liver Physiol 2007; 293: G1106-13.
5. Hvid-Jensen F, Pedersen L, Drewes AM et al. Incidence of adenocarcinoma among patients with Barrett ?s esophagus. N Engl J Med 2011; 365: 1375-83.
6. Shaheen NJ, Sharma P, Overholt BF et al. Radiofrequency ablation in Barrett esophagus with dysplasia. N Engl J Med 2009; 360: 2277-88.
7. Roorda AK, Marcus SN, Triadafilopoulos G. Early experience with radiofrequency energy ablation therapy for Barrett esophagus with and without dysplasia. Dis Esophagus 2007; 20: 516-22.
8. Hernandez JC, Reicher S, Chung D et al. Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia. Endoscopy 2008; 40: 388-92.
9. Falk GW. Radiofrequency ablation of Barrett's esophagus: should everybody get it? Gastroenterology 2009; 136: 2399-401
10. Shaheen NJ, Overholt BF, Sampliner RE et al. Durability of radio frequency ablation in Barrett esophagus with dysplasia. Gastroenterology 2011; 141: 460-8.
11. Gupta IR, Ryan AK. Claudins: unlocking the code to tight junction function during embryogenesis and in disease. Clin Genet 2010; 77: 314-25.
12. Tobey NA, Argote CM, Vanegas XC et al. Electrical parameters and ion species for active transport in human esophageal stratifi ed squamous epithelium and Barrett's specialized columnar epithelium. Am J Physiol Gastrointest Liver Physiol 2007; 293: G264-70.
13. Paulson TG, Xu L, Sanchez C et al. Neosquamous epithelium does not typically arise from Barrett epithelium. Clin Cancer Res 2006; 12: 1701-6.
14. Jovov B, Que J, Tobey NA et al. Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease. Am J Gastroenterol 2011; 106: 1039-47.
15. Tobey NA, Carson JL, Alkiek RA et al. Dilated intercellular spaces: a morphological feature of acid reflux-damaged human esophageal epithelium. Gastroenterology 1996; 111: 1200-5.
16. Caviglia R, Ribolsi M, Gentile M et al. Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007; 25: 629-36.
17. Sifrim D. Acid, weakly acidic and non-acid gastro-oesophageal reflux: differences, prevalence and clinical relevance. Eur J Gastroenterol Hepatol 2004; 16: 823-30.
18. Gerson LB, Shetler K, Triadafilopoulos G. Control of intra-oesophageal and intra-gastric pH with proton pump inhibitors in patients with Barrett's oesophagus. Dig Liver Dis 2005; 37: 651-8.
19. Sharma VK, Wang KK, Overholt BF et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 2007; 65: 185-95.
20. Kahaleh M, Van Laethem JL, Nagy N et al. Long-term follow-up and factors predictive of recurrence in Barrett esophagus treated by argon plasma coagulation and acid suppression. Endoscopy 2002; 34: 950-5.
21. Yoshida N. Inflammation and oxidative stress in gastroesophageal reflux disease. J Clin Biochem Nutr 2007; 40: 13-23.
22. Eksteen JA, Scott PA, Perry I et al. Inflammation promotes Barrett metaplasia and cancer: a unique role for TNFalpha. Eur J Cancer Prev 2001; 10: 163-6.
23. Titi M, Overhiser A, Ulusarac O et al. Development of sub-squamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus. Gastroenterology 2012; 143: 564.e1-6-e1.
24. Zhou C, Tsai TH, Lee HC et al. Characterization of buried glands before and after radiofrequency ablation by using 3-dimensional optical coherence tomography. Gastrointest Endosc 2012; 76: 32-40.
25. Van Itallie C, Rahner C, Anderson JM. Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest 2001; 107: 1319-27.
26. Oshima T, Koseki J, Chen X et al. Acid modulates the squamous epithelial barrier function by modulating the localization of claudins in the superfi cial layers. Lab Invest 2012; 92: 22-31.